AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 241 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,262,104 | -18.9% | 27,443 | +1.3% | 0.01% | -16.7% |
| Q2 2023 | $1,556,575 | +56.8% | 27,085 | +2.3% | 0.01% | +50.0% |
| Q1 2023 | $992,813 | +254.3% | 26,475 | +164.8% | 0.00% | +300.0% |
| Q4 2022 | $280,200 | -15.1% | 10,000 | -14.9% | 0.00% | -50.0% |
| Q3 2022 | $330,000 | -19.3% | 11,755 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $409,000 | +102.5% | 11,755 | +108.6% | 0.00% | +100.0% |
| Q1 2022 | $202,000 | -24.6% | 5,635 | -60.0% | 0.00% | -50.0% |
| Q3 2016 | $268,000 | +22.4% | 14,105 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $219,000 | +21.7% | 13,585 | -9.6% | 0.00% | 0.0% |
| Q1 2016 | $180,000 | – | 15,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |